Aehr Test Systems (AEHR) - Stock Analysis

Last updated: Apr 25, 2026

TechnologyClosed

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

One of the clearest fresh catalyst setups: record $41 million follow-on order announced on 2026-04-16 and $37.2 million bookings with book-to-bill above 3.5x on 2026-04-07. Shares surged about 160% over 21 trading days, showing exceptional momentum tied to AI-related burn-in demand.

Loading chart data...

Idea window: 4/20/2026 – 4/27/2026Sector: Technology

AI Analyst Overview

Last Price
$80.51
Market Cap
$2.78B
1D Return
-9.01%
YTD Return
+298.76%

Loading chart data...

Valuation Metrics

P/E
-237.9
P/B
19.6
P/S
61.5
EV/EBITDA
-205.2
Div Yield
—

Fundamental Analysis

4.0

Key Financial Insights: • Liquidity Strength • Negative Cash Flow • Weak Margins AEHR has a strong balance sheet and improving liquidity, but persistent losses, negative cash flow, and weakening margins make the stock look expensive relative to fundamentals.

neutral
negative

Price Behavior

7.0

Key Price Behavior Insights: • Strong breakout momentum • Near-peak consolidation • Overextension risk Support Level: $90 to $93 Resistance Level: $97 to $98 AEHR is showing powerful short-term bullish momentum after a ~178% surge, but the stock looks stretched and now needs to hold the $90–$93 support area to avoid a pullback.

bullish
overextended

Sentiment & News

8.0

Key News Insights: • Backlog surge • AI demand • Elevated valuation Aehr Test Systems' stock has surged on record backlog, strong AI/data center demand, and a $41 million follow-on order despite weak revenue, ongoing cash burn, and stretched valuation.

AIGrowth
HighValuation
AI

AI Summary

6.0
Neutral

AEHR has shifted from a weak semiconductor equipment name to a high-beta AI infrastructure proxy, with record bookings and a major hyperscale follow-on order improving the growth outlook, but the stock remains risky because revenue, margins, and free cash flow have yet to confirm that backlog is converting into durable profitability.

AIOpportunity
ExecutionRisk
Backlog
AI summary updated 3 days ago

Description

Aehr Test Systems designs and supplies test and burn-in equipment for logic, memory and optical integrated circuits, supporting both wafer-level and packaged-device verification. Its product set includes systems and handling solutions that enable full-wafer contact testing, singulated die and module burn-in, and compact single-wafer reliability checks across a range of device types and power levels. The company was incorporated in 1977 and is based in Fremont, California.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Apr 20Apr 27AEHRAehr Test Systems
One of the clearest fresh catalyst setups: record $41 million follow-on order announced on 2026-04-16 and $37.2 million bookings with book-to-bill above 3.5x on 2026-04-07. Shares surged about 160% over 21 trading days, showing exceptional momentum tied to AI-related burn-in demand.
Closed-1.8%
Apr 13Apr 20AEHRAehr Test Systems
AEHR shows classic speculative heat: ~102% 21‑day price surge, strong order bookings (book‑to‑bill >3.5x, AI/datacenter and silicon photonics wins) and raised 2H FY26 bookings visibility, making it a high‑volatility, order‑driven momentum trade over the coming sessions.
Closed+25.8%
Apr 2Apr 9AEHRAehr Test Systems
High-risk semiconductor test beneficiary with an imminent catalyst: multiple recent production orders (FOX wafer-level systems, silicon-photonics and GaN programs), reinstated H2 revenue guidance ($25–30M) and a sharp rebound (~+31% from March 30 to April 1) into the 2026-04-07 Q3 earnings release create a classic near-term event/momentum setup.
Closed+55.4%
Mar 9Mar 16AEHRAehr Test Systems
Semicap name with stacked recent orders: in Feb–early Mar 2026 announced multiple production-stage and wafer-level burn-in orders (including a $14M FOX + WaferPak order on 2026-02-26 and a follow-on silicon-photonics order on 2026-03-03). Stock ran ~55% into a 44.03 high then pulled back ~19% to 35.61 by 2026-03-06, leaving a high-volatility setup where confirmation of order-to-revenue conversion could trigger another sharp upside leg.
Closed-8.3%
Feb 23Mar 2AEHRAehr Test Systems
An initial production purchase order from a leading hyperscaler for multiple Sonoma systems and more than $5.5m in recent Q3 orders, tied to next‑gen AI processors, is catalyzing strong technical momentum (break around $34) and elevated investor interest, positioning AEHR for near‑term upside as those orders convert to reported revenue despite weak recent cash flow and margins.
Closed+28.3%
Dec 17Dec 24AEHRAehr Test Systems
Record Q3 revenues with strong AI/data center product demand, production capacity expansion, institutional buying, and improving gross margins underpin short-term growth, although unprofitability and technical price volatility suggest cautious optimism.
Closed+2.7%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.